Grenon Xavier, Pinget Christophe, Wasserfallen Jean-Blaise
HTA Unit,Medical directorate,Lausanne University Hospital,
Int J Technol Assess Health Care. 2016 Jan;32(3):116-21. doi: 10.1017/S0266462316000258. Epub 2016 Aug 5.
Hospital-based health technology assessment (HB-HTA) has been introduced to help hospital management in decision making about the adoption of new health technologies (HTs). We reviewed the accuracy of the expected medical impact of HTs assessed at our hospital, as well as the acceptance of this process by clinicians.
For each HT adopted between 2002 and 2011, a semi-structured interview with the involved clinician was conducted, assessing (i) the perceived utility of the HB-HTA process, (ii) the accuracy of the new HT's expected medical impact as compared with observed patient data from the year 2012, and (iii) the compliance with the indications of the HB-HTA report.
Over the 10-year period, forty HB-HTAs were carried out, of which thirty-four led to acceptance. Twenty-seven of the twenty-eight clinicians involved in these thirty-four HTs accepted the interview and 85 percent acknowledged the utility of the HB-HTA process. Five of the thirty-four HTs were no longer in use. For the twenty-nine remaining HTs, observed patients' number was as expected in eight, higher in four, lower in fifteen, and not available in two cases. Available average length of stay was 61 percent longer than expected. Two HTs had a higher complication rate and three a lower success rate. Indications evolved in 55 percent of HTs after a few years (seven restrictions, six broadenings, and three other changes).
A HB-HTA process is useful to improve quality in decision making. Follow-up analysis should routinely be performed to adapt HB-HTA reports' conclusions to practical experience and new scientific evidence.
医院健康技术评估(HB-HTA)已被引入,以帮助医院管理层在采用新健康技术(HT)方面进行决策。我们回顾了我院评估的HT预期医疗影响的准确性,以及临床医生对这一过程的接受程度。
对于2002年至2011年期间采用的每种HT,对相关临床医生进行了半结构化访谈,评估(i)HB-HTA过程的感知效用,(ii)与2012年观察到的患者数据相比,新HT预期医疗影响的准确性,以及(iii)对HB-HTA报告适应症的遵守情况。
在这10年期间,共进行了40次HB-HTA,其中34次被接受。参与这34种HT的28名临床医生中有27名接受了访谈,85%的人认可HB-HTA过程的效用。34种HT中有5种不再使用。对于其余29种HT,观察到的患者数量在8种情况下与预期一致,4种情况下高于预期,15种情况下低于预期,2种情况下数据不可用。可用的平均住院时间比预期长61%。2种HT的并发症发生率较高,3种HT的成功率较低。几年后,55%的HT适应症发生了变化(7次限制、6次放宽和3次其他变化)。
HB-HTA过程有助于提高决策质量。应定期进行随访分析,以使HB-HTA报告的结论适应实际经验和新的科学证据。